...
首页> 外文期刊>Clinical neurology and neurosurgery >Does hemorrhagic presentation in cerebral arteriovenous malformations affect obliteration rate after gamma knife radiosurgery?
【24h】

Does hemorrhagic presentation in cerebral arteriovenous malformations affect obliteration rate after gamma knife radiosurgery?

机译:脑动静脉畸形的出血表现会影响伽玛刀放射手术后的闭塞率吗?

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Radiosurgery has been widely adopted for the treatment of cerebral AVMs. However radiosurgical treatment of patients with hemorrhagic presentation is fraught with risk of rebleed during latency period. The present study intends to analyze the obliteration rate, time to obliteration and chances of rebleed in patients with hemorrhagic versus non-hemorrhagic clinical presentation in cerebral arteriovenous malformations (AVMs) treated with gamma knife radiosurgery (GKS). PATIENTS AND METHODS: Of all the patients with cerebral AVMs treated from May 1997 to June 2006, 157 patients with neuroimaging follow up with digital subtraction angiography harboring 160 AVM nidii formed the study group. The mean age of presentation was 28 years (range, 6-58 years); mean nidus volume being 3.64 cm3 (range, 0.011-36.6 cm3). The mean follow up period was 70 months (range, 13-121 months). All the patients were treated predominantly by primary GKS with use of adjunctive pre-GKS embolization in selected patients. RESULTS: A total of 103 (64%) patients presented with hemorrhage. There was no difference in the obliteration rate (69% versus 67%, p=0.672), mean latency period to obliteration (30 months versus 32 months, p=0.1989) and chances of hemorrhage (4.8% versus 3.5%, p=0.690) in patients with hemorrhagic as compared to non-hemorrhagic presentation. CONCLUSION: Prior hemorrhage does not affect the outcome after GKS in terms of obliteration rate, latency to obliteration as well as chances of hemorrhage during latency period. Gamma knife appears equally efficacious irrespective of the mode of clinical presentation in the management of cerebral AVMs; a concomitant use of pre-GKS embolization/surgery may be needed in patients with hemorrhagic presentation in selected cases, however.
机译:目的:放射外科已被广泛用于治疗脑AVM。然而,对于有出血表现的患者,放射外科治疗充满了潜伏期出血的风险。本研究旨在分析接受伽玛刀放射治疗(GKS)治疗的脑动静脉畸形(AVM)出血与非出血性临床表现的患者的闭塞率,闭塞时间和再出血机会。患者与方法:1997年5月至2006年6月治疗的所有脑AVM患者中,有157例神经影像学随访患者进行了数字减影血管造影术,其中包含160例AVM nidii。报告的平均年龄为28岁(范围为6-58岁); nidus平均体积为3.64 cm3(范围为0.011-36.6 cm3)。平均随访期为70个月(范围13-121个月)。所有患者均以原发性GKS为主,并在选定的患者中使用辅助性GKS栓塞前治疗。结果:共有103名患者(64%)出现出血。闭塞率(69%比67%,p = 0.672),闭塞平均潜伏期(30个月比32个月,p = 0.1989)和出血几率(4.8%比3.5%,p = 0.690)没有差异。 )与非出血性表现相比有出血性。结论:就闭塞率,闭塞潜伏期以及潜伏期出血的机会而言,先前的出血不会影响GKS后的预后。不管临床AVM的治疗方式如何,伽玛刀的效果都一样。但是,在某些情况下,有出血表现的患者可能需要同时使用GKS栓塞/手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号